National Institute for Health and Care Excellence
Depression 2022
Ce document comprend 68 pages.
Contenu en anglais
Synthèse
Significant revision to NICE depression guidance. Stepped-care model restructured around severity and patient preference. Psychological therapies (CBT, behavioural activation) recommended first-line for mild-to-moderate depression. SSRIs remain recommended pharmacotherapy. New evidence on digital therapeutics and exercise integrated.
Évaluation du niveau de preuve
Système de gradation
Class I–II
Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.
En bref
- Organisme
- National Institute for Health and Care Excellence
- Date de publication
- 2022
- Région
- UK
- Langue
- English
- Système de gradation
- Class I–II
Mots-clés
- Depression
- MDD
- SSRI
- CBT
- Stepped care
- Psychotherapy
Autres recommandations en psychiatrie
- European Society of Child and Adolescent Psychiatry (ESCAP) practical guidance for clinicians and mental health services regarding child to adult mental health service transitions and managed discharge at the service boundaryEuropean Society of Child and Adolescent Psychiatry (ESCAP) · 2026
- Assessment and Management of Patients at Risk for SuicideDepartment of Veterans Affairs (VA) and Department of Defense (DoD) · 2024
